Global Flow Cytometry in Oncology and Immunology Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08246126

Publication Date:

August 21, 2024

Pages:

122

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Flow cytometry is a powerful technology that is widely used in both oncology and immunology research. It is a technique used to analyze the physical and chemical properties of cells in a heterogeneous population, by labeling and detecting specific molecules on the surface of cells. The resulting data can provide information about the number, size, and complexity of cells in a sample, as well as their phenotype and function.
In oncology, flow cytometry is often used to analyze cancer cells and to monitor the progression of the disease. For example, flow cytometry can be used to identify and quantify cancer stem cells, which are thought to be responsible for tumor initiation and recurrence. It can also be used to measure the expression of tumor-associated antigens, which are molecules expressed by cancer cells that can be targeted by immunotherapy.
Overall, flow cytometry is a versatile tool that has many applications in oncology and immunology research. It can provide valuable information about the biology of cells and their interactions with other cells and molecules, and can help researchers to develop new diagnostic and therapeutic approaches for cancer and other diseases
The global Flow Cytometry in Oncology and Immunology market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
The 鈥淔low Cytometry in Oncology and Immunology Industry Forecast鈥� looks at past sales and reviews total world Flow Cytometry in Oncology and Immunology sales in 2023, providing a comprehensive analysis by region and market sector of projected Flow Cytometry in Oncology and Immunology sales for 2024 through 2030. With Flow Cytometry in Oncology and Immunology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Flow Cytometry in Oncology and Immunology industry.
This Insight Report provides a comprehensive analysis of the global Flow Cytometry in Oncology and Immunology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Flow Cytometry in Oncology and Immunology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Flow Cytometry in Oncology and Immunology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Flow Cytometry in Oncology and Immunology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Flow Cytometry in Oncology and Immunology.
The global increase in HIV diagnoses is a significant market factor for flow cytometry, and this is because the flow cytometry technique is specifically used for HIV diagnosis. In flow cytometry, light scattering is utilized to identify cells. These cells receive particular markers known as CDs depending on the type of scattering (clusters of differentiation). The main market players are concentrating on creating new products, which is anticipated to propel market growth over the forecast year.
This report presents a comprehensive overview, market shares, and growth opportunities of Flow Cytometry in Oncology and Immunology market by product type, application, key players and key regions and countries.
Segmentation by type
Products
Services
Segmentation by application
Immunology
Oncology
Solid Tumor
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Agilent
ABYNTEK BIOPHARMA
Bio-Rad Laboratories
Cell Signaling Technology
Cytek Biosciences
Danaher Corporation,
DiaSorin S.p.A (Luminex Corporation),
Enzi Biochem Inc
Laboratory Corporation of America Holdings,
Merck KGaA
Miltenyi Biotec
NeoGenomics Laboratories
OPKO Health
Sony Group Corporation
Thermo Fisher Scientific Inc.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Flow Cytometry in Oncology and Immunology Market Size 2019-2030
2.1.2 Flow Cytometry in Oncology and Immunology Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Flow Cytometry in Oncology and Immunology Segment by Type
2.2.1 Products
2.2.2 Services
2.3 Flow Cytometry in Oncology and Immunology Market Size by Type
2.3.1 Flow Cytometry in Oncology and Immunology Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Flow Cytometry in Oncology and Immunology Market Size Market Share by Type (2019-2024)
2.4 Flow Cytometry in Oncology and Immunology Segment by Application
2.4.1 Immunology
2.4.2 Oncology
2.4.3 Solid Tumor
2.5 Flow Cytometry in Oncology and Immunology Market Size by Application
2.5.1 Flow Cytometry in Oncology and Immunology Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Flow Cytometry in Oncology and Immunology Market Size Market Share by Application (2019-2024)
3 Flow Cytometry in Oncology and Immunology Market Size by Player
3.1 Flow Cytometry in Oncology and Immunology Market Size Market Share by Players
3.1.1 Global Flow Cytometry in Oncology and Immunology Revenue by Players (2019-2024)
3.1.2 Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Players (2019-2024)
3.2 Global Flow Cytometry in Oncology and Immunology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Flow Cytometry in Oncology and Immunology by Regions
4.1 Flow Cytometry in Oncology and Immunology Market Size by Regions (2019-2024)
4.2 Americas Flow Cytometry in Oncology and Immunology Market Size Growth (2019-2024)
4.3 APAC Flow Cytometry in Oncology and Immunology Market Size Growth (2019-2024)
4.4 Europe Flow Cytometry in Oncology and Immunology Market Size Growth (2019-2024)
4.5 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size Growth (2019-2024)
5 Americas
5.1 Americas Flow Cytometry in Oncology and Immunology Market Size by Country (2019-2024)
5.2 Americas Flow Cytometry in Oncology and Immunology Market Size by Type (2019-2024)
5.3 Americas Flow Cytometry in Oncology and Immunology Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Flow Cytometry in Oncology and Immunology Market Size by Region (2019-2024)
6.2 APAC Flow Cytometry in Oncology and Immunology Market Size by Type (2019-2024)
6.3 APAC Flow Cytometry in Oncology and Immunology Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Flow Cytometry in Oncology and Immunology by Country (2019-2024)
7.2 Europe Flow Cytometry in Oncology and Immunology Market Size by Type (2019-2024)
7.3 Europe Flow Cytometry in Oncology and Immunology Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Flow Cytometry in Oncology and Immunology by Region (2019-2024)
8.2 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Type (2019-2024)
8.3 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Flow Cytometry in Oncology and Immunology Market Forecast
10.1 Global Flow Cytometry in Oncology and Immunology Forecast by Regions (2025-2030)
10.1.1 Global Flow Cytometry in Oncology and Immunology Forecast by Regions (2025-2030)
10.1.2 Americas Flow Cytometry in Oncology and Immunology Forecast
10.1.3 APAC Flow Cytometry in Oncology and Immunology Forecast
10.1.4 Europe Flow Cytometry in Oncology and Immunology Forecast
10.1.5 Middle East & Africa Flow Cytometry in Oncology and Immunology Forecast
10.2 Americas Flow Cytometry in Oncology and Immunology Forecast by Country (2025-2030)
10.2.1 United States Flow Cytometry in Oncology and Immunology Market Forecast
10.2.2 Canada Flow Cytometry in Oncology and Immunology Market Forecast
10.2.3 Mexico Flow Cytometry in Oncology and Immunology Market Forecast
10.2.4 Brazil Flow Cytometry in Oncology and Immunology Market Forecast
10.3 APAC Flow Cytometry in Oncology and Immunology Forecast by Region (2025-2030)
10.3.1 China Flow Cytometry in Oncology and Immunology Market Forecast
10.3.2 Japan Flow Cytometry in Oncology and Immunology Market Forecast
10.3.3 Korea Flow Cytometry in Oncology and Immunology Market Forecast
10.3.4 Southeast Asia Flow Cytometry in Oncology and Immunology Market Forecast
10.3.5 India Flow Cytometry in Oncology and Immunology Market Forecast
10.3.6 Australia Flow Cytometry in Oncology and Immunology Market Forecast
10.4 Europe Flow Cytometry in Oncology and Immunology Forecast by Country (2025-2030)
10.4.1 Germany Flow Cytometry in Oncology and Immunology Market Forecast
10.4.2 France Flow Cytometry in Oncology and Immunology Market Forecast
10.4.3 UK Flow Cytometry in Oncology and Immunology Market Forecast
10.4.4 Italy Flow Cytometry in Oncology and Immunology Market Forecast
10.4.5 Russia Flow Cytometry in Oncology and Immunology Market Forecast
10.5 Middle East & Africa Flow Cytometry in Oncology and Immunology Forecast by Region (2025-2030)
10.5.1 Egypt Flow Cytometry in Oncology and Immunology Market Forecast
10.5.2 South Africa Flow Cytometry in Oncology and Immunology Market Forecast
10.5.3 Israel Flow Cytometry in Oncology and Immunology Market Forecast
10.5.4 Turkey Flow Cytometry in Oncology and Immunology Market Forecast
10.5.5 GCC Countries Flow Cytometry in Oncology and Immunology Market Forecast
10.6 Global Flow Cytometry in Oncology and Immunology Forecast by Type (2025-2030)
10.7 Global Flow Cytometry in Oncology and Immunology Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Agilent
11.1.1 Agilent Company Information
11.1.2 Agilent Flow Cytometry in Oncology and Immunology Product Offered
11.1.3 Agilent Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Agilent Main Business Overview
11.1.5 Agilent Latest Developments
11.2 ABYNTEK BIOPHARMA
11.2.1 ABYNTEK BIOPHARMA Company Information
11.2.2 ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Product Offered
11.2.3 ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 ABYNTEK BIOPHARMA Main Business Overview
11.2.5 ABYNTEK BIOPHARMA Latest Developments
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Information
11.3.2 Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Product Offered
11.3.3 Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bio-Rad Laboratories Main Business Overview
11.3.5 Bio-Rad Laboratories Latest Developments
11.4 Cell Signaling Technology
11.4.1 Cell Signaling Technology Company Information
11.4.2 Cell Signaling Technology Flow Cytometry in Oncology and Immunology Product Offered
11.4.3 Cell Signaling Technology Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Cell Signaling Technology Main Business Overview
11.4.5 Cell Signaling Technology Latest Developments
11.5 Cytek Biosciences
11.5.1 Cytek Biosciences Company Information
11.5.2 Cytek Biosciences Flow Cytometry in Oncology and Immunology Product Offered
11.5.3 Cytek Biosciences Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cytek Biosciences Main Business Overview
11.5.5 Cytek Biosciences Latest Developments
11.6 Danaher Corporation,
11.6.1 Danaher Corporation, Company Information
11.6.2 Danaher Corporation, Flow Cytometry in Oncology and Immunology Product Offered
11.6.3 Danaher Corporation, Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Danaher Corporation, Main Business Overview
11.6.5 Danaher Corporation, Latest Developments
11.7 DiaSorin S.p.A (Luminex Corporation),
11.7.1 DiaSorin S.p.A (Luminex Corporation), Company Information
11.7.2 DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Product Offered
11.7.3 DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 DiaSorin S.p.A (Luminex Corporation), Main Business Overview
11.7.5 DiaSorin S.p.A (Luminex Corporation), Latest Developments
11.8 Enzi Biochem Inc
11.8.1 Enzi Biochem Inc Company Information
11.8.2 Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Product Offered
11.8.3 Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Enzi Biochem Inc Main Business Overview
11.8.5 Enzi Biochem Inc Latest Developments
11.9 Laboratory Corporation of America Holdings,
11.9.1 Laboratory Corporation of America Holdings, Company Information
11.9.2 Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Product Offered
11.9.3 Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Laboratory Corporation of America Holdings, Main Business Overview
11.9.5 Laboratory Corporation of America Holdings, Latest Developments
11.10 Merck KGaA
11.10.1 Merck KGaA Company Information
11.10.2 Merck KGaA Flow Cytometry in Oncology and Immunology Product Offered
11.10.3 Merck KGaA Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Merck KGaA Main Business Overview
11.10.5 Merck KGaA Latest Developments
11.11 Miltenyi Biotec
11.11.1 Miltenyi Biotec Company Information
11.11.2 Miltenyi Biotec Flow Cytometry in Oncology and Immunology Product Offered
11.11.3 Miltenyi Biotec Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Miltenyi Biotec Main Business Overview
11.11.5 Miltenyi Biotec Latest Developments
11.12 NeoGenomics Laboratories
11.12.1 NeoGenomics Laboratories Company Information
11.12.2 NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Product Offered
11.12.3 NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 NeoGenomics Laboratories Main Business Overview
11.12.5 NeoGenomics Laboratories Latest Developments
11.13 OPKO Health
11.13.1 OPKO Health Company Information
11.13.2 OPKO Health Flow Cytometry in Oncology and Immunology Product Offered
11.13.3 OPKO Health Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 OPKO Health Main Business Overview
11.13.5 OPKO Health Latest Developments
11.14 Sony Group Corporation
11.14.1 Sony Group Corporation Company Information
11.14.2 Sony Group Corporation Flow Cytometry in Oncology and Immunology Product Offered
11.14.3 Sony Group Corporation Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Sony Group Corporation Main Business Overview
11.14.5 Sony Group Corporation Latest Developments
11.15 Thermo Fisher Scientific Inc.
11.15.1 Thermo Fisher Scientific Inc. Company Information
11.15.2 Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Product Offered
11.15.3 Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Thermo Fisher Scientific Inc. Main Business Overview
11.15.5 Thermo Fisher Scientific Inc. Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂